Chylothorax in newborns after cardiac surgery: a rare complication?
Cardiac surgery
Chylothorax
Congenital heart disease
Neonates
Newborn
Journal
European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
27
11
2022
accepted:
04
01
2023
revised:
02
01
2023
medline:
10
5
2023
pubmed:
17
1
2023
entrez:
16
1
2023
Statut:
ppublish
Résumé
The aim of this study was to analyze patients diagnosed with chylothorax after congenital heart disease surgery among a cohort of neonatal patients, comparing the evolution, complications, and prognosis after surgery of patients who were and were not diagnosed with chylothorax, and to analyze possible risk factors that may predict the appearance of chylothorax in this population. Retrospective and observational study included all neonates (less than 30 days since birth) who underwent congenital heart disease surgery in a level III neonatal intensive care department. We included infants born between January 2014 and December 2019. We excluded those infants who were born before 34 weeks of gestational age or whose birth weight was less than 1800 g. We also excluded catheter lab procedures and patent ductus arteriosus closure surgeries. Included patients were divided into two groups depending on whether they were diagnosed with chylothorax or not after surgery, and both groups were compared in terms of perinatal-obstetrical information, surgical data, and NICU course after surgery. We included 149 neonates with congenital heart disease surgery. Thirty-one patients (20.8%) developed chylothorax, and in ten patients (32.3%), it was considered large volume chylothorax. Regarding the evolution of these patients, 22 infants responded to general dietetic measures, a catheter procedure was performed in 9, and 5 of them finally required pleurodesis. Cardiopulmonary bypass, median sternotomy, and delayed sternal closure were the surgical variables associated with higher risks of chylothorax. Patients with chylothorax had a longer duration of inotropic support and mechanical ventilation and took longer to reach full enteral feeds. As complications, they had higher rates of cholestasis, catheter-related sepsis, and venous thrombosis. Although there were no differences in neonatal mortality, patients with chylothorax had a higher rate of mortality after the neonatal period. In a multiple linear regression model, thrombosis and cardiopulmonary bypass multiplied by 10.0 and 5.1, respectively, the risk of chylothorax and have an umbilical vein catheter decreases risk. We have found a high incidence of chylothorax after neonatal cardiac surgery, which prolongs the average stay and causes significant morbidity and mortality. We suggested that chylothorax could be an underestimated complication of congenital heart disease surgery during the neonatal period. • Acquired chylothorax in the neonatal period usually appears as a complication of congenital heart disease surgery, being the incidence quite variable among the different patient series (2.5-16.8%). The appearance of chylothorax as a complication of a cardiac surgery increases both mortality and morbidity in these patients, which makes it a quality improvement target in the postsurgical management of this population. •Most of the published studies include pediatric patients of all ages, from newborns to teenagers, and there is a lack of studies focusing on neonatal populations. The main strength of our study is that it reports, to the best of our knowledge, one of the largest series of neonatal patients receiving surgery for congenital heart disease in the first 30 days after birth. We have found a high incidence of chylothorax after cardiac surgery during the neonatal period compared to other studies. We suggested that chylothorax could be an underestimated complication of congenital heart disease surgery during this period of life.
Identifiants
pubmed: 36646910
doi: 10.1007/s00431-023-04808-5
pii: 10.1007/s00431-023-04808-5
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1569-1578Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Rocha G, Arnet V, Soares P et al (2021) Chylothorax in the neonate—a stepwise approach algorithm. Pediatr Pulmonol 56:3093–3105
doi: 10.1002/ppul.25601
pubmed: 34324269
Benítez I, Copons C, Castillo F (2008) Avances en terapéutica: Tratamiento del quilotórax. Anales de Pediatria Continuada 6:159–165. https://doi.org/10.1016/S1696-2818(08)74871-6
doi: 10.1016/S1696-2818(08)74871-6
Beghetti M, la Scala G, Belli D et al (2000) Etiology and management of pediatric chylothorax. J Pediatr 136:653–658. https://doi.org/10.1067/mpd.2000.104287
doi: 10.1067/mpd.2000.104287
pubmed: 10802499
Borasino S, Diaz F, el Masri K et al (2014) Central venous lines are a risk factor for chylothorax in infants after cardiac surgery. World J Pediatr Congenit Heart Surg 5:522–526. https://doi.org/10.1177/2150135114550723
doi: 10.1177/2150135114550723
pubmed: 25324248
Christofe NM, Pessotti CFX, Paiva L, Jatene IB (2017) Incidence and treatment of chylothorax in children undergoing corrective surgery for congenital heart diseases. Braz J Cardiovasc Surg 32:390–393. https://doi.org/10.21470/1678-9741-2017-0011
Costa KM, Saxena AK (2018) Surgical chylothorax in neonates: management and outcomes. World J Pediatr 14:110–115. https://doi.org/10.1007/s12519-018-0134-x
doi: 10.1007/s12519-018-0134-x
pubmed: 29508361
Efrati O, Barak A (2002) Pleural effusions in the pediatric population. Pediatr Rev 23:417–426
doi: 10.1542/pir.23.12.417
pubmed: 12456894
Church JT, Antunez AG, Dean A et al (2017) Evidence-based management of chylothorax in infants. J Pediatr Surg 52:907–912. https://doi.org/10.1016/j.jpedsurg.2017.03.010
doi: 10.1016/j.jpedsurg.2017.03.010
pubmed: 28342580
Tutor JD (2014) Chylothorax in infants and children. Pediatrics 133:722–733. https://doi.org/10.1542/peds.2013-2072
doi: 10.1542/peds.2013-2072
pubmed: 24685960
Copons Fernández C, Benítez Segura I, Castillo Salinas F, Salcedo Abizanda S (2008) Neonatal chylothorax: aetiology, clinical course and efficacy of treatment. An Pediatr (Barc) 68:224–231. https://doi.org/10.1157/13116701
doi: 10.1157/13116701
pubmed: 18358132
Jenkins KJ, Gauvreau K, Newburger JW et al (2002) Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 123:110–118. https://doi.org/10.1067/mtc.2002.119064
doi: 10.1067/mtc.2002.119064
pubmed: 11782764
Mery CM, Moffett BS, Khan MS et al (2014) Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. J Thorac Cardiovasc Surg 147:678–86.e1; discussion 685–6. https://doi.org/10.1016/j.jtcvs.2013.09.068
Day TG, Zannino D, Golshevsky D et al (2018) Chylothorax following paediatric cardiac surgery: a case-control study. Cardiol Young 28:222–228. https://doi.org/10.1017/S1047951117001731
doi: 10.1017/S1047951117001731
pubmed: 28835310
Matsuo S, Takahashi G, Konishi A, Sai S (2013) Management of refractory chylothorax after pediatric cardiovascular surgery. Pediatr Cardiol 34:1094–1099. https://doi.org/10.1007/s00246-012-0607-y
doi: 10.1007/s00246-012-0607-y
pubmed: 23229292
Biewer ES, Zürn C, Arnold R et al (2010) Chylothorax after surgery on congenital heart disease in newborns and infants -risk factors and efficacy of MCT-diet. J Cardiothorac Surg 5:127. https://doi.org/10.1186/1749-8090-5-127
doi: 10.1186/1749-8090-5-127
pubmed: 21144029
pmcid: 3009966
Kazanci SY, McElhinney DB, Thiagarajan R et al (2013) Obstruction of the superior vena cava after neonatal extracorporeal membrane oxygenation: association with chylothorax and outcome of transcatheter treatment. Pediatr Crit Care Med 14:37–43. https://doi.org/10.1097/PCC.0b013e31825b5270
doi: 10.1097/PCC.0b013e31825b5270
pubmed: 23295835
Giglia TM, Massicotte MP, Tweddell JS et al (2013) Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation 128:2622–2703. https://doi.org/10.1161/01.cir.0000436140.77832.7a
doi: 10.1161/01.cir.0000436140.77832.7a
pubmed: 24226806
Manlhiot C, Menjak IB, Brandão LR et al (2011) Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery. Circulation 124:1511–1519. https://doi.org/10.1161/CIRCULATIONAHA.110.006304
doi: 10.1161/CIRCULATIONAHA.110.006304
pubmed: 21911785
Murphy LD, Benneyworth BD, Moser EAS et al (2018) Analysis of patient characteristics and risk factors for thrombosis after surgery for congenital heart disease. Pediatr Crit Care Med 19:1146–1152. https://doi.org/10.1097/PCC.0000000000001743
doi: 10.1097/PCC.0000000000001743
pubmed: 30234677
Anton N, Cox PN, Massicotte MP et al (2009) Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trial. Pediatrics 123:e453–e458. https://doi.org/10.1542/peds.2008-1508
doi: 10.1542/peds.2008-1508
pubmed: 19237438
McCulloch MA, Conaway MR, Haizlip JA et al (2008) Postoperative chylothorax development is associated with increased incidence and risk profile for central venous thromboses. Pediatr Cardiol 29:556–561. https://doi.org/10.1007/s00246-007-9140-9
doi: 10.1007/s00246-007-9140-9
pubmed: 18030412
Faraoni D, Emani S, Halpin E et al (2017) Relationship between transfusion of blood products and the incidence of thrombotic complications in neonates and infants undergoing cardiac surgery. J Cardiothorac Vasc Anesth 31:1943–1948. https://doi.org/10.1053/j.jvca.2017.04.039
doi: 10.1053/j.jvca.2017.04.039
pubmed: 28533072
Bauman ME, Moher C, Bruce AK et al (2013) Chylothorax in children with congenital heart disease: incidence of thrombosis. Thromb Res 132:e83–e85. https://doi.org/10.1016/j.thromres.2013.06.014
doi: 10.1016/j.thromres.2013.06.014
pubmed: 23830210
Bernet-Buettiker V, Waldvogel K, Cannizzaro V, Albisetti M (2006) Antithrombin activity in children with chylothorax. Eur J Cardiothorac Surg 29:406–409. https://doi.org/10.1016/j.ejcts.2005.12.015
doi: 10.1016/j.ejcts.2005.12.015
pubmed: 16439146
Kaipa S, Mastropietro CW, Bhai H et al (2020) Upper body peripherally inserted central catheter in pediatric single ventricle patients. World J Cardiol 12:484–491. https://doi.org/10.4330/wjc.v12.i10.484
doi: 10.4330/wjc.v12.i10.484
pubmed: 33173567
pmcid: 7596420
Tawhai P, van den Boom J, Cama J (2022) Chylothorax associated with a PICC line in a very low birth weight infant. J Pediatr Surg Case Rep 76. https://doi.org/10.1016/j.epsc.2021.102120
Hsu H-F, Chou Y-H, Wang C-R, Wu S-C (2003) Catheter-related superior vena cava syndrome complicated by chylothorax in a premature infant. Chang Gung Med J 26:782–786
pubmed: 14717215
Oulego-Erroz I, Fernández-García A, Álvarez-Juan B et al (2020) Ultrasound-guided supraclavicular cannulation of the brachiocephalic vein may reduce central line-associated bloodstream infection in preterm infants. Eur J Pediatr 179:1655–1663. https://doi.org/10.1007/s00431-020-03663-y
doi: 10.1007/s00431-020-03663-y
pubmed: 32382789
pmcid: 7223997
Habas F, Baleine J, Milési C et al (2018) Supraclavicular catheterization of the brachiocephalic vein: a way to prevent or reduce catheter maintenance-related complications in children. Eur J Pediatr 177:451–459. https://doi.org/10.1007/s00431-017-3082-x
doi: 10.1007/s00431-017-3082-x
pubmed: 29322352
Sánchez Luna M, Caballero Martín S, Gomez S, de Orgaz MDC et al (2020) Skimmed breast milk in newborns with chylothorax: options with a personalised nutrition unit. An Pediatr (Engl Ed) 93:194–195. https://doi.org/10.1016/j.anpedi.2019.10.011
doi: 10.1016/j.anpedi.2019.10.011
pubmed: 31810889
Fernández Alvarez JR, Kalache KD, Graŭel EL (1999) Management of spontaneous congenital chylothorax: oral medium-chain triglycerides versus total parenteral nutrition. Am J Perinatol 16:415–420. https://doi.org/10.1055/s-1999-6816
doi: 10.1055/s-1999-6816
pubmed: 10772201
Zheng J, Chen Y-Y, Zhang C-Y et al (2020) Incidence and nutritional management of chylothorax after surgery for congenital heart diseases in children. Heart Surg Forum 23:E902–E906. https://doi.org/10.1532/hsf.3219
doi: 10.1532/hsf.3219
pubmed: 33399533
Bellini C, Cabano R, de Angelis LC et al (2018) Octreotide for congenital and acquired chylothorax in newborns: a systematic review. J Paediatr Child Health 54:840–847. https://doi.org/10.1111/jpc.13889
doi: 10.1111/jpc.13889
pubmed: 29602276
Loomba RS, Wong J, Davis M et al (2021) Medical interventions for chylothorax and their impacts on need for surgical intervention and admission characteristics: a multicenter, retrospective insight. Pediatr Cardiol 42:543–553. https://doi.org/10.1007/s00246-020-02512-x
doi: 10.1007/s00246-020-02512-x
pubmed: 33394111
Savla JJ, Itkin M, Rossano JW, Dori Y (2017) Post-operative chylothorax in patients with congenital heart disease. J Am Coll Cardiol 69:2410–2422. https://doi.org/10.1016/j.jacc.2017.03.021
doi: 10.1016/j.jacc.2017.03.021
pubmed: 28494978
Stringel G, Mercer S, Bass J (1984) Surgical management of persistent postoperative chylothorax in children. Can J Surg 27:543–546
pubmed: 6498647
Allen EM, van Heeckeren DW, Spector ML, Blumer JL (1991) Management of nutritional and infectious complications of postoperative chylothorax in children. J Pediatr Surg 26:1169–1174. https://doi.org/10.1016/0022-3468(91)90325-n
doi: 10.1016/0022-3468(91)90325-n
pubmed: 1779326
le Nué R, Molinaro F, Gomes-Ferreira C et al (2010) Surgical management of congenital chylothorax in children. Eur J Pediatr Surg 20:307–311. https://doi.org/10.1055/s-0030-1254164
doi: 10.1055/s-0030-1254164
pubmed: 20577953